Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neuroprotective effects of PPAR-γ agonist rosiglitazone in N171-82Q mouse model of Huntington's disease
Authors
Keywords
-
Journal
JOURNAL OF NEUROCHEMISTRY
Volume 125, Issue 3, Pages 410-419
Publisher
Wiley
Online
2013-02-04
DOI
10.1111/jnc.12190
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Metabolic State Determines Sensitivity to Cellular Stress in Huntington Disease: Normalization by Activation of PPARγ
- (2012) Youngnam N. Jin et al. PLoS One
- The dysfunction of hepatic transcriptional factors in mice with Huntington's Disease
- (2011) Ming-Chang Chiang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Protective effect of pioglitazone, a PPARγ ligand, in a 3 nitropropionic acid model of Huntington's disease
- (2011) Maddalena Napolitano et al. BRAIN RESEARCH BULLETIN
- Mutant Huntingtin Causes Metabolic Imbalance by Disruption of Hypothalamic Neurocircuits
- (2011) Sofia Hult et al. Cell Metabolism
- Mitogen- and stress-activated protein kinase 1-induced neuroprotection in Huntington's disease: role on chromatin remodeling at the PGC-1-alpha promoter
- (2011) Elodie Martin et al. HUMAN MOLECULAR GENETICS
- Pharmacologic activation of mitochondrial biogenesis exerts widespread beneficial effects in a transgenic mouse model of Huntington's disease
- (2011) Ashu Johri et al. HUMAN MOLECULAR GENETICS
- Conditional BDNF release under pathological conditions improves Huntington's disease pathology by delaying neuronal dysfunction
- (2011) Albert Giralt et al. Molecular Neurodegeneration
- Peroxisome proliferation–associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity
- (2011) Sabrina Diano et al. NATURE MEDICINE
- Neuroprotective role of Sirt1 in mammalian models of Huntington's disease through activation of multiple Sirt1 targets
- (2011) Mali Jiang et al. NATURE MEDICINE
- Paradoxical function of orexin/hypocretin circuits in a mouse model of Huntington's disease
- (2011) Rhîannan H. Williams et al. NEUROBIOLOGY OF DISEASE
- PPARgamma rescue of the mitochondrial dysfunction in Huntington's disease
- (2011) Ming-Chang Chiang et al. NEUROBIOLOGY OF DISEASE
- Rosiglitazone decreases peroxisome proliferator receptor-gamma levels in microglia and inhibits TNF-alpha production: new evidences on neuroprotection in a progressive Parkinson's disease model
- (2011) A.R. Carta et al. NEUROSCIENCE
- Activation of Peroxisome Proliferator-Activated Receptor Gamma by Rosiglitazone Increases Sirt6 Expression and Ameliorates Hepatic Steatosis in Rats
- (2011) Soo Jin Yang et al. PLoS One
- Brain-Derived Neurotrophic Factor in Patients with Huntington's Disease
- (2011) Chiara Zuccato et al. PLoS One
- The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1α
- (2010) Lei Zhong et al. CELL
- Full-length huntingtin levels modulate body weight by influencing insulin-like growth factor 1 expression
- (2010) M. A. Pouladi et al. HUMAN MOLECULAR GENETICS
- Modulation of energy deficiency in Huntington's disease via activation of the peroxisome proliferator-activated receptor gamma
- (2010) Ming-Chang Chiang et al. HUMAN MOLECULAR GENETICS
- Impairment of PGC-1alpha expression, neuropathology and hepatic steatosis in a transgenic mouse model of Huntington's disease following chronic energy deprivation
- (2010) R. K. Chaturvedi et al. HUMAN MOLECULAR GENETICS
- Mitochondrial matters of the brain: the role in Huntington’s disease
- (2010) C. Turner et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- The interrelationship between mitochondrial dysfunction and transcriptional dysregulation in Huntington disease
- (2010) Youngnam N. Jin et al. JOURNAL OF BIOENERGETICS AND BIOMEMBRANES
- SIRT6 Deficiency Results in Severe Hypoglycemia by Enhancing Both Basal and Insulin-stimulated Glucose Uptake in Mice
- (2010) Cuiying Xiao et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SIRT6 in DNA repair, metabolism and ageing
- (2010) D. B. Lombard et al. JOURNAL OF INTERNAL MEDICINE
- BDNF Overexpression in the Forebrain Rescues Huntington's Disease Phenotypes in YAC128 Mice
- (2010) Y. Xie et al. JOURNAL OF NEUROSCIENCE
- Huntington's disease
- (2010) T Hoppitt et al. LANCET
- Huntington's disease: from molecular pathogenesis to clinical treatment
- (2010) Christopher A Ross et al. LANCET NEUROLOGY
- Brief ampakine treatments slow the progression of Huntington's disease phenotypes in R6/2 mice
- (2010) Danielle A. Simmons et al. NEUROBIOLOGY OF DISEASE
- Peroxisome Proliferator-Activated Receptor-γ (PPAR-γ) Activation Confers Functional Neuroprotection in Global Ischemia
- (2010) Zahra Fatehi-Hassanabad et al. NEUROTOXICITY RESEARCH
- PGC-1 , A Potential Therapeutic Target for Early Intervention in Parkinson's Disease
- (2010) B. Zheng et al. Science Translational Medicine
- Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease
- (2009) Angela Bithell et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Impaired mitochondrial trafficking in Huntington's disease
- (2009) Xiao-Jiang Li et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Role of mitochondrial dysfunction in the pathogenesis of Huntington's disease
- (2009) Rodrigo A. Quintanilla et al. BRAIN RESEARCH BULLETIN
- PGC-1α, SIRT1 and AMPK, an energy sensing network that controls energy expenditure
- (2009) Carles Cantó et al. CURRENT OPINION IN LIPIDOLOGY
- PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson’s disease
- (2009) Nicoletta Schintu et al. EUROPEAN JOURNAL OF NEUROSCIENCE
- Impaired PGC-1α function in muscle in Huntington's disease
- (2009) Rajnish K. Chaturvedi et al. HUMAN MOLECULAR GENETICS
- Decreased BDNF Levels Are a Major Contributor to the Embryonic Phenotype of Huntingtin Knockdown Zebrafish
- (2009) H. Diekmann et al. JOURNAL OF NEUROSCIENCE
- RETRACTED: Activation of the PPAR/PGC-1α Pathway Prevents a Bioenergetic Deficit and Effectively Improves a Mitochondrial Myopathy Phenotype
- (2008) Tina Wenz et al. Cell Metabolism
- Rosiglitazone Treatment Prevents Mitochondrial Dysfunction in Mutant Huntingtin-expressing Cells
- (2008) Rodrigo A. Quintanilla et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Brain-derived neurotrophic factor modulates the severity of cognitive alterations induced by mutant huntingtin: Involvement of phospholipaseCγ activity and glutamate receptor expression
- (2008) A. Giralt et al. NEUROSCIENCE
- Peroxisome Proliferator-Activated Receptor-γin Amyotrophic Lateral Sclerosis and Huntington’s Disease
- (2008) Mahmoud Kiaei PPAR Research
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started